SV2A Attenuates Interictal anxiety in Pharmacoresistant Epilepsy via the SYT3-GluA2 Axis.
OBJECTIVE Synaptic vesicle glycoprotein 2A (SV2A) is an established target of antiseizure therapy; however, its role in excitatory synaptic function and downstream postsynaptic machinery remains poorly defined. This study examined whether SV2A limits excitotoxic signaling by recruiting synaptotagmin-3 (SYT3), thereby m...